Cineverse Q1 Revenue Soars 175% to $30.6M, Reaffirms FY27 Guidance
CNVS sits 66% above its 52-week low of $1.77.
Summary
Cineverse reported Q1 FY2027 revenue of $30.6 million, up 175% year-over-year, driven by technology acquisitions. The company reaffirmed full-year guidance of $115-$120 million in revenue and $10-$20 million in Adjusted EBITDA, but posted a net loss of $5.8 million and has a working capital deficit of $18.9 million.
Key Events · Earnings and Guidance · CNVS
-
Revenue Surges 175%
Q1 FY2027 revenue reached $30.6 million, up from $11.1 million in the prior-year quarter, driven by the first full quarter of contributions from the Giant Worldwide and IndiCue acquisitions.
-
Net Loss Widens
Net loss attributable to common stockholders was $5.8 million, or $0.28 per share, compared to a loss of $3.6 million, or $0.21 per share, in the prior-year quarter.
-
Adjusted EBITDA Improves
Adjusted EBITDA was $0.5 million, a $2.6 million improvement over the prior-year quarter, reflecting cost controls and acquisition synergies.
-
Full-Year Guidance Reaffirmed
Management reaffirmed fiscal 2027 guidance of $115-$120 million in revenue and $10-$20 million in Adjusted EBITDA, citing the cost reduction program and strong streaming metrics.
Analysis · CNVS · Trade & Services
Cineverse's first-quarter results show a dramatic revenue surge driven by recent acquisitions, but the company still posted a net loss of $5.8 million and carries a working capital deficit of $18.9 million. The reaffirmed full-year guidance of $115-$120 million in revenue and $10-$20 million in Adjusted EBITDA signals management confidence in the integration and cost-cutting plan, but the balance sheet remains tight with only $4.3 million in cash. The stock is likely to react to the revenue growth and guidance reaffirmation, but the persistent losses and liquidity concerns temper the positive narrative.
At the time of this filing, CNVS was trading at $2.93 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $67.2M. The 52-week trading range was $1.77 to $6.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.